Related Experiment Video
Updated: Jul 6, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Syncope as a probable side effect to combination antiretroviral therapy initiated during primary HIV-1 infection
Dorte Lybaek1, Carsten Schade Larsen
1Department of Infectious Diseases, Skejby Hospital, University Hospital of Aarhus, DK-8200 Aarhus N, Denmark. dlybaek@dadlnet.dk
Abstract:
A previously healthy young man experienced several episodes of syncope while being treated with tenofovir, emtricitabine and nevirapine initiated during primary HIV-1 infection. Symptoms disappeared after discontinuation of antiretroviral therapy and we suggest that syncope may be a side effect to one of the three antiretroviral drugs that has not been described previously.
Related Concept Videos
Cryptococcal Meningitis
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Antiviral Nucleoside Inhibitors
Cytomegalovirus Disease
Inhibitors of Viral Protein Synthesis

